MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹123 Cr | ₹98 Cr | ₹80 Cr | ₹72 Cr | ₹63 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹123 Cr |
Mar2023 | ₹98 Cr |
Mar2022 | ₹80 Cr |
Mar2021 | ₹72 Cr |
Mar2020 | ₹63 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹123 Cr | 25.78 | |
Mar2023 | ₹98 Cr | 22.36 | |
Mar2022 | ₹80 Cr | 10.74 | |
Mar2021 | ₹72 Cr | 14.66 | |
Mar2020 | ₹63 Cr | - |
Compare Long Term Provisions of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹99,979.2 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 2.1% |
3.7% |
9.5% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses